[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Page 21339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Developing Novel Diagnostic Tests To Improve 
Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity 
Announcement (FOA) CI10-002; Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8 a.m.-5 p.m., May 18, 2010 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Clifton 
Road, Atlanta, GA 30337, Telephone: (770) 979-1100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Developing Novel Diagnostic Tests to Improve 
Surveillance for Antimicrobial Resistant Pathogens, FOA CI10-002.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2293.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-9519 Filed 4-22-10; 8:45 am]
BILLING CODE 4163-18-P